PEX34 encodes Pex34p, a peroxisomal integral membrane protein in Saccharomyces cerevisiae involved in regulating peroxisome number, division, and contact sites with mitochondria . Key characteristics include:
Proliferation: Deletion of PEX34 reduces peroxisome numbers under constitutive division and oleic acid-induced proliferation conditions .
Genetic Interactions: Acts synergistically with Pex25p and Pex27p (Pex11-family proteins) to maintain peroxisome populations .
Tethering Function: Overexpression of Pex34p expands peroxisome-mitochondria (PerMit) contacts, facilitating citrate shuttle activity for β-oxidation .
Metabolic Impact: Enhances CO₂ production from fatty acids via peroxisomal citrate synthase (Cit2p)-dependent pathways .
ER Stress Response: pex34Δ cells show impaired adaptation to endoplasmic reticulum stress (ERS), with reduced viability under tunicamycin-induced stress .
While no studies explicitly using a PEX34 antibody are described in the provided sources, such a tool could enable:
Subcellular Localization: Confirming peroxisomal membrane localization in wild-type and mutant strains.
Expression Analysis: Quantifying Pex34p levels during peroxisome proliferation or stress responses.
Interaction Studies: Co-immunoprecipitation with Pex11-family proteins (e.g., Pex25p, Pex27p) or mitochondrial tethers.
KEGG: sce:YCL056C
STRING: 4932.YCL056C
PEX34 is a peroxisomal integral membrane protein primarily involved in regulating peroxisome numbers and proliferation in yeast. It functions both independently and in concert with the PEX11 protein family members (PEX11p, PEX25p, and PEX27p) to control peroxisome populations under conditions of both peroxisome proliferation and constitutive peroxisome division. PEX34 is significant for research because it represents a critical component in understanding peroxisome biogenesis, division, and population control mechanisms, which are important for cellular metabolism and response to environmental changes .
PEX34 is a peroxisomal integral membrane protein. Organelle extraction experiments using hypotonic lysis in dilute alkali Tris buffer, followed by ultracentrifugation, have shown that GFP-PEX34 cofractionates with peroxisomal integral membrane proteins like PEX3 and peroxisomal peripheral membrane proteins like PEX27 to the membrane fraction (Ti8P), while soluble peroxisomal matrix proteins like Pot1p are found almost exclusively in the soluble fraction (Ti8S) . This indicates that PEX34 is firmly embedded in the peroxisomal membrane rather than being a soluble or peripheral membrane protein.
Based on published research protocols, fluorescence microscopy using GFP-tagged PEX34 has been effectively used to study its localization to peroxisomes. Confocal fluorescence microscopy has been employed to track peroxisome numbers using markers like Pot1p-GFP in wild-type versus pex34Δ cells . For co-localization studies, dual fluorescence imaging with markers like DsRed-SKL (a peroxisomal matrix marker) and GFP-PEX34 can confirm peroxisomal localization . Additionally, subcellular fractionation followed by immunoblotting has been used to confirm the membrane association of PEX34 .
Researchers have successfully quantified peroxisome numbers using time-course imaging of cells expressing fluorescently-tagged peroxisomal markers. In one approach, cells expressing oleic acid–inducible Pot1p-GFP were grown in glucose-containing medium and then transferred to medium containing oleic acid as the sole carbon source to induce peroxisome proliferation. Images were collected by confocal fluorescence microscopy at regular intervals (e.g., every 2 hours), and the number of labeled peroxisomes per cell was quantified . For constitutive peroxisome division studies, researchers have used constitutively expressed markers like Mdh2p-GFP. These approaches allow for statistically robust quantification of peroxisome numbers under different genetic backgrounds and conditions.
When performing immunofluorescence with PEX34 antibodies, several controls should be included:
Negative controls: Using pex34Δ mutant strains to confirm antibody specificity
Positive controls: Co-staining with known peroxisomal markers (e.g., PEX3-GFP)
Subcellular marker controls: Including markers for other organelles (e.g., mitochondria, ER) to ensure specificity of localization
Secondary antibody-only controls: To account for non-specific binding
Competitive inhibition: Pre-incubation of the antibody with purified PEX34 protein to demonstrate specificity
These controls help validate the specificity of antibody staining and ensure accurate interpretation of localization results.
PEX34 antibodies can be employed in several advanced techniques to study protein-protein interactions:
Co-immunoprecipitation (Co-IP): PEX34 antibodies can precipitate PEX34 along with its interacting partners from cell lysates. This approach has potential to validate and extend the yeast two-hybrid results showing interactions between PEX34 and PEX11 family proteins (PEX11p, PEX25p, and PEX27p) .
Proximity-dependent biotin identification (BioID): By fusing a biotin ligase to PEX34, researchers can identify proximal proteins that become biotinylated and then use antibodies to detect these interactions.
Fluorescence resonance energy transfer (FRET): Using fluorescently labeled antibodies against PEX34 and potential interacting partners to detect energy transfer as evidence of close proximity.
Immunogold electron microscopy: To visualize the precise localization of PEX34 and its interacting partners at the ultrastructural level.
These approaches would complement genetic interaction studies and provide biochemical evidence for functional interactions.
When studying PEX34 under different growth conditions, several methodological considerations are critical:
Carbon source selection: In yeast studies, different carbon sources significantly affect peroxisome proliferation. Oleic acid induces peroxisome proliferation, while glucose maintains basal peroxisome numbers. Experimental design should account for these differences when analyzing PEX34 function .
Time-course analysis: Peroxisome proliferation is a dynamic process. When studying PEX34's role, time-course experiments are essential, as demonstrated by studies showing differences in peroxisome numbers between wild-type and pex34Δ cells over 8 hours of oleic acid induction .
Strain background considerations: Different yeast strains may have variable baseline peroxisome numbers or proliferation rates. Using isogenic strains for comparisons is crucial.
Quantification methodology: Consistent methods for counting peroxisomes across experiments are essential for reliable data. This includes standardizing imaging parameters, cell selection criteria, and statistical analysis approaches.
Protein expression levels: When using antibodies to detect PEX34, considering native expression levels versus overexpression scenarios is important for interpreting results.
To investigate PEX34's role in de novo peroxisome formation, researchers can employ sophisticated experimental approaches:
Reintroduction experiments: Using inducible systems (e.g., GAL promoter) to reintroduce peroxisome biogenesis factors like PEX3 in cells lacking peroxisomes (e.g., pex3Δ) with or without PEX34 (pex3Δ pex34Δ). This approach has revealed that peroxisome number is significantly reduced in pex34Δ pex3Δ cells upon reintroduction of PEX3-GFP compared to pex3Δ cells .
Time-lapse imaging: Tracking the formation of new peroxisomes using fluorescently tagged markers to observe differences in de novo formation rates.
Biochemical fractionation: Isolating ER-derived pre-peroxisomal vesicles during early stages of biogenesis to determine PEX34's presence and role.
Pulse-chase experiments: Using inducible, photoactivatable fluorescent proteins to track newly synthesized peroxisomal proteins and their incorporation into forming peroxisomes.
Import competency assays: Determining whether peroxisomes formed in the absence of PEX34 are fully import-competent for matrix proteins, as demonstrated by co-labeling experiments with markers like DsRed-SKL .
Several challenges may arise when detecting PEX34, with corresponding solutions:
Low signal intensity: PEX34 may be expressed at relatively low levels naturally. This can be addressed by:
Using signal amplification methods like tyramide signal amplification
Optimizing fixation and permeabilization protocols for better antibody accessibility
Considering epitope retrieval methods if applicable
Using more sensitive detection systems
Specificity concerns: Ensuring antibody specificity for PEX34 is crucial. Researchers should:
Validate antibodies using pex34Δ strains as negative controls
Perform western blots to confirm antibody recognizes a protein of the expected size
Consider using tagged versions of PEX34 (e.g., GFP-PEX34) if antibodies are problematic
Membrane protein solubilization: As an integral membrane protein, PEX34 may require special extraction conditions. Consider:
When confronted with discrepancies in data regarding PEX34 function across different experimental systems, researchers should:
Evaluate genetic background differences: Different yeast strains may have compensatory mechanisms affecting peroxisome numbers and proliferation.
Compare growth conditions: Ensure that media composition, temperature, and growth phase are standardized across experiments. Growth on oleic acid versus glucose can dramatically alter peroxisome dynamics .
Consider protein expression levels: Overexpression versus endogenous expression of PEX34 can lead to different outcomes. PEX34 overexpression increases peroxisome numbers, while deletion reduces them .
Analyze interaction effects: PEX34 functions in concert with other peroxins, particularly the PEX11 family. Different levels of these interacting partners might affect PEX34's apparent function .
Examine temporal aspects: The timing of observations can affect results, as peroxisome proliferation is dynamic. Time-course experiments rather than endpoint analyses may resolve apparent discrepancies.
Validate detection methods: Ensure that different detection methods (fluorescence microscopy, biochemical fractionation, etc.) are properly controlled and calibrated.
To optimize protein-protein interaction studies involving PEX34, researchers should consider these strategies:
Cross-linking approaches: Due to the potentially transient nature of some peroxisomal protein interactions, mild cross-linking prior to immunoprecipitation may capture more interaction partners.
Detergent selection: The choice of detergents for solubilizing membrane proteins is critical. A panel of detergents should be tested to identify those that maintain interactions while effectively solubilizing PEX34.
Quantitative techniques: Moving beyond qualitative interaction studies, techniques like quantitative mass spectrometry following immunoprecipitation can provide stoichiometric information about complexes.
Recombinant protein approaches: Using purified recombinant proteins for in vitro binding assays can complement in vivo approaches and help determine direct versus indirect interactions.
Domain mapping: Creating truncated versions of PEX34 can help map interaction domains, similar to approaches used with other peroxins.
Alternative systems: While two-hybrid analysis has been used successfully to demonstrate PEX34 interactions with the PEX11 family , complementary approaches like split-GFP or FRET may provide additional spatial information about where these interactions occur within cells.
While current research on PEX34 has focused primarily on yeast models, PEX34 antibodies could potentially contribute to understanding peroxisome-related diseases through:
Identifying human homologs: Antibodies designed to recognize conserved epitopes might help identify potential human homologs of PEX34, expanding our understanding of peroxisome regulation in humans.
Comparative studies: Examining PEX34 expression and function across model organisms using specific antibodies could reveal evolutionarily conserved mechanisms relevant to human disease.
Studying regulatory networks: PEX34 antibodies could help elucidate regulatory networks affecting peroxisome homeostasis, potentially revealing dysregulated pathways in peroxisomal disorders.
Biomarker development: If human homologs are identified, antibodies could be used to develop biomarkers for monitoring peroxisome dysfunction in disease states.
Therapeutic target validation: Antibody-based studies could help validate potential therapeutic targets in the peroxisome biogenesis pathway.
Emerging techniques that could advance our understanding of PEX34 dynamics include:
Super-resolution microscopy: Techniques like PALM, STORM, or STED could reveal submicroscopic details of PEX34 distribution within the peroxisomal membrane and its relationship to other peroxins.
Live-cell imaging with photoactivatable or photoconvertible fluorophores: These approaches would enable real-time tracking of PEX34 movements during peroxisome division or de novo formation.
Optogenetic tools: Light-inducible protein interaction systems could allow temporal control over PEX34 interactions to study their dynamic effects on peroxisome biogenesis.
CRISPR-based approaches: CRISPR-mediated tagging of endogenous PEX34 with reporters would allow visualization without overexpression artifacts.
Single-molecule tracking: Following individual PEX34 molecules could reveal diffusion dynamics and interaction kinetics within the peroxisomal membrane.
Quantitative import assays: Adapting in vitro peroxisomal protein import assays, like the biotinylated luciferase system , to study how PEX34 affects import efficiency could provide functional insights.
These advanced techniques, combined with specific antibodies, would provide unprecedented insights into PEX34 biology and peroxisome biogenesis.